Description
Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly.
Various approaches are being used to develop an effective RSV vaccine.
The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development